COVARMED FARMA

Active

Private limited companyfounded 2011active for 15 yearsDoenaertstraat(Mar) 11, 8510 Kortrijk, BelgiumKBO/BCE: BE 0835.154.657

From the official registers: KBO 14 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

COVARMED FARMA has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €309,601. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 73% of 274 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

COVARMED FARMAActiveChecked score 96/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 30-03-2011 Normal situation
Legal form: Private limited company
Registered office: Doenaertstraat(Mar) 11, 8510 Kortrijk
Activity: Manufacture of medical and dental instruments and supplies NACE 32500and 3 others
Establishment unit: 2.198.882.904 8510 Kortrijk, since 30-03-2011
Financial year end: 30 September
Peppol: Reachable since 21-10-2026

Company details

Who decides

Board

Curafin NVDirector · since 07-12-2017
First Aid Services BVDirector · since 07-12-2017
Trihold NVDirector · since 13-09-2021

Shareholders

Curafin100%annual accounts 30-09-2025

Board & ownership

How it is doing

96 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts to 30-09-2025

Gross margin: €525,162; ▲ 47.4%
Turnover: ≈ €1.2m; estimated
Profit: €309,601; ▲ 60.4%
Equity: €1.1m; ▲ 16.8%
Total assets: €1.7m; ▼ 8.7%
Staff: 1 FTE; =

2025 accounts on time

Filed on 30-04-2026PDF

Financials

Why 96lowers riskLiquidity: current ratio 3.30, cash €236,055Equity €1.1m (65.7% of total assets)Figures for financial year 2025 (filed 30-04-2026)Founded in 2011Show the evidence

Checked score

Score 2025

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 68% of its sector peers (NACE 32, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 91+15

equity 65.7% of total assets

Liquidity 55+13

short-term debt 30.0% · cash 14.0%

Profitability 92+10

return on assets 18.3%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (1,142 companies, NACE 32, micro)

Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.2%▲ +0.1 percentage points vs 03-2026highest value 05-2026: < 0.1%▼ -0.2 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €100,000 on 30-day terms is acceptable

Liquidity ample (current ratio 3.3, compared with 2.31 in 2024, above the usual 1.5; short-term debt: 30% and cash: 14% of total assets), and 34.3% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro): better than 71% on solvency, 54% on liquidity, 80% on profitability and 68% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Liquidity: current ratio 3.30, cash €236,055

NBB · annual accounts

Equity €1.1m (65.7% of total assets)

NBB · annual accounts

Figures for financial year 2025 (filed 30-04-2026)

NBB · annual accounts

Founded in 2011

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

on the day

2024

93 days early

2023

15 days early

2022

40 days early

2021

95 days early

2020

9 days early

2019

on the day

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 36 days before the deadline; the sector median (NACE 32) for financial year 2024 is 2 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 21 March (4 of the last 5 filed years within 53 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-09-2026 year end01-11-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 11% on net resultsector median €25,404 · 274 companies €309,601 View
Positive: Result rose in 2025from €193,010 to €309,601 ▲ 60.4% View
Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Positive: 7 profitable years in a rowprofit 2025: €309,601 7 years View
A director leftlatest change 17-04-2026 · 3 in office 1 left View

Documents

Key facts about COVARMED FARMA

What is the company number of COVARMED FARMA?: 0835.154.657. In Belgium the VAT number is the company number with BE in front: BE 0835.154.657.
Where is COVARMED FARMA based?: The registered office is at Doenaertstraat(Mar) 11, 8510 Kortrijk.Company details
What does COVARMED FARMA do?: According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
What is the legal form of COVARMED FARMA?: Private limited company (BV).
When was COVARMED FARMA founded?: On 30-03-2011.
Is COVARMED FARMA still active?: Yes, COVARMED FARMA is an active enterprise in the KBO register.
How many employees does COVARMED FARMA have?: On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of COVARMED FARMA?: ≈ €1.2m in financial year 2025. Estimated from the gross margin of €525,162: probably between €750,000 and €2.1m, based on 2,285 comparable companies of the same size. A rough estimate.
Is COVARMED FARMA profitable?: In financial year 2025, COVARMED FARMA made a profit of €309,601.
Where can I find the annual accounts of COVARMED FARMA?: COVARMED FARMA filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of COVARMED FARMA due?: By 30-04-2027, for financial year 2026.Timeline